• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Trividia Health issues label correction for blood glucose monitors after death

February 6, 2026 By Sean Whooley

Trividia Health True Metrix Blood Glucose Meters (1)
The True Metrix blood glucose meters. [Image courtesy of Trividia Health]
Trividia Health announced today that it initiated a label correction for its True Metrix blood glucose monitoring systems.

The label update affects True Metrix, True Metrix Air, True Metrix Go and True Metrix Pro blood glucose monitoring systems. Distribution regions include the U.S., UK, Mexico, Australia and the Caribbean. It requires a modification to the systems’ owner’s booklets/system instructions for use.

Trividia Health said the update relates to the E-5 Error Code in the “Messages” section of its owner’s booklets/instructions. This change emphasizes that users must seek medical attention immediately if they receive this code and are experiencing symptoms of high glucose.

The system displays this error code for a very high blood glucose event (greater than 600 mg/dL) or in the event of a test strip error. As currently written, the instructions could potentially lead to a delay in treatment if the user fails to seek medical attention immediately. A delay in treatment can result in serious adverse health consequences or death, especially for users with very high blood glucose levels.

Since the global launch of True Metrix in August 2014, Trividia has received 114 reports of serious injuries and one report of death associated with the E-5 error code.

The correction affects all True Metrix-branded blood glucose meters distributed in the affected regions, including co-branded products sold under store or distribution partner names.

Customers may continue to use the True Metrix products and do not need to return or replace them. The company notified the FDA of its action.

Filed Under: Diabetes, Patient Monitoring, Technology Tagged With: Trividia Health

IN CASE YOU MISSED IT

  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS